Company Name | ÎÚÑ»´«Ã½. |
---|---|
Date Established | December 6, 1941 |
Head Office | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan |
Telephone | 81-3-3817-3700 |
Representatives | Haruo Naito, Representative Corporate Officer and CEO
Yasushi Okada, Representative Corporate Officer Keisuke Naito, Representative Corporate Officer and Executive Vice President |
Capital | 44,986 million Yen (as of March 31, 2024) |
Scope of Business | Research and development, manufacture, sale and import and export of pharmaceuticals |
Organization Chart | |
Employees | Consolidated : 11,067
Non-Consolidated : 2,984 (as of March 31, 2024) |
Production Plants | Kawashima Industrial Park (Gifu Prefecture)
Kashima Plant (Ibaraki Prefecture) ÎÚÑ»´«Ã½ Manufacturing Ltd. (U.K.) ÎÚÑ»´«Ã½ China Inc. Suzhou Plant (China) ÎÚÑ»´«Ã½ (Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China) ÎÚÑ»´«Ã½ Pharmaceuticals India Pvt. Ltd. (India), etc. |
Laboratories | Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Industrial Park (Gifu Prefecture) Kashima Business Office (Ibaraki Prefecture) Kobe Research Laboratories (Hyogo Prefecture) ÎÚÑ»´«Ã½ Center for Genetics Guided Dementia Discovery (G2D2) (U.S.A.) Exton Site (U.S.A.) Hatfield Research Institute (U.K.), etc. |
Overseas Sales Offices | ÎÚÑ»´«Ã½ Inc. (U.S.A.)
ÎÚÑ»´«Ã½ Ltd. (U.K.) ÎÚÑ»´«Ã½ GmbH (Germany) ÎÚÑ»´«Ã½ S.A.S. (France) ÎÚÑ»´«Ã½ China Inc. (China) ÎÚÑ»´«Ã½ Korea Inc. (South Korea), etc. |
Stock Information
Fiscal Year End | March 31 |
---|---|
Record Date for Dividend | Year-end dividend - March 31
Interim dividend - September 30 |
Annual Shareholders' Meeting | June |
Stock Exchange Listings | Tokyo Stock Exchange |
Stock Trading Unit | 100 shares |
Ticker Code | 4523 |